|
KMID : 0882420160900010063
|
|
Korean Journal of Medicine
2016 Volume.90 No. 1 p.63 ~ p.67
|
|
|
Myelodysplastic Syndrome and Minimal Change Nephrotic Syndrome treated with Steroid Challenge
|
|
이상아:Lee Sang-Ah
임장환:Lim Jang-Hwan/장지훈:Jang Ji-Hun/장순희:Chang Soon-Hee/곽은경:Kwak Eun-Kyoung/이덕현:Lee Duck-Hyun/이선아:Lee Sun-Ah
|
|
|
Abstract
|
|
|
|
Glomerulonephritis associated with malignancy is deemed to be paraneoplastic glomerulonephritis. Myelodysplastic syndrome (MDS) is a group of heterogeneous clonal hematopoietic stem cell disorders characterized by impaired hematopoietic cell differentiation and cytopenia. The pathophysiology of MDS is thought to be immune-mediated in part. A few reports have documented various forms of glomerulonephritis in patients with MDS and suggested that immune dysregulation is important in the development of paraneoplastic glomerulonephritis. Here, we report a patient with MDS and refractory anemia with excess blast-2 accompanied by minimal change nephrotic syndrome. The patient was treated with prednisolone, and the nephrotic-range proteinuria and pancytopenia improved markedly.
|
|
|
KEYWORD
|
|
|
Myelodysplastic syndromes, Nephrotic syndrome, Steroids
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|